158 related articles for article (PubMed ID: 35996285)
1. Evaluation of the MolecuTech
Cho EJ; Kang MR; Kim JH; Lee JI; Son ES; Park CH; Aung WW; Lee JS
Int J Tuberc Lung Dis; 2022 Sep; 26(9):869-874. PubMed ID: 35996285
[No Abstract] [Full Text] [Related]
2. Early detection of multidrug- and pre-extensively drug-resistant tuberculosis from smear-positive sputum by direct sequencing.
Chen J; Peng P; Du Y; Ren Y; Chen L; Rao Y; Wang W
BMC Infect Dis; 2017 Apr; 17(1):300. PubMed ID: 28438132
[TBL] [Abstract][Full Text] [Related]
3. Utility of the REBA MTB-Rifa® assay for rapid detection of rifampicin resistant Mycobacterium tuberculosis.
Cho E; Shamputa IC; Kwak HK; Lee J; Lee M; Hwang S; Jeon D; Kim CT; Cho S; Via LE; Barry CE; Lee JS
BMC Infect Dis; 2013 Oct; 13():478. PubMed ID: 24128118
[TBL] [Abstract][Full Text] [Related]
4. The diagnostic accuracy of the GenoType(®) MTBDRsl assay for the detection of resistance to second-line anti-tuberculosis drugs.
Theron G; Peter J; Richardson M; Barnard M; Donegan S; Warren R; Steingart KR; Dheda K
Cochrane Database Syst Rev; 2014 Oct; (10):CD010705. PubMed ID: 25353401
[TBL] [Abstract][Full Text] [Related]
5. Drug-resistant Mycobacterium tuberculosis among Nepalese patients at a tuberculosis referral center.
Chand AB; Basnet A; Maharjan B; Rai G; Joshi YP; Bhatt LR; Sen B; Rai SK
PLoS One; 2024; 19(5):e0301210. PubMed ID: 38709710
[TBL] [Abstract][Full Text] [Related]
6. Direct detection of resistance to fluoroquinolones/SLIDs in sputum specimen by GenoType MTBDRsl v.2.0 assay A study from Eastern Uttar Pradesh, India.
Singh K; Kumari R; Gupta S; Tripathi R; Srivastava A; Shakya V; Gupta A; Anupurba S
Ann Clin Microbiol Antimicrob; 2021 Aug; 20(1):56. PubMed ID: 34446022
[TBL] [Abstract][Full Text] [Related]
7. Laboratory evaluation of the Anyplex™ II MTB/MDR and MTB/XDR tests based on multiplex real-time PCR and melting-temperature analysis to identify Mycobacterium tuberculosis and drug resistance.
Igarashi Y; Chikamatsu K; Aono A; Yi L; Yamada H; Takaki A; Mitarai S
Diagn Microbiol Infect Dis; 2017 Dec; 89(4):276-281. PubMed ID: 28974394
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the QuantaMatrix Multiplexed Assay Platform for Molecular Diagnosis of Multidrug- and Extensively Drug-Resistant Tuberculosis Using Clinical Strains Isolated in Myanmar.
Chang Y; Kim S; Kim Y; Ei PW; Hwang D; Lee J; Chang CL; Lee H
Ann Lab Med; 2020 Mar; 40(2):142-147. PubMed ID: 31650730
[TBL] [Abstract][Full Text] [Related]
9. Transmission, distribution and drug resistance-conferring mutations of extensively drug-resistant tuberculosis in the Western Cape Province, South Africa.
Oostvogels S; Ley SD; Heupink TH; Dippenaar A; Streicher EM; De Vos E; Meehan CJ; Dheda K; Warren R; Van Rie A
Microb Genom; 2022 Apr; 8(4):. PubMed ID: 35471145
[TBL] [Abstract][Full Text] [Related]
10. Detection of Rifampicin- and Isoniazid-Resistant Mycobacterium tuberculosis Using the Quantamatrix Multiplexed Assay Platform System.
Wang HY; Uh Y; Kim S; Cho E; Lee JS; Lee H
Ann Lab Med; 2018 Nov; 38(6):569-577. PubMed ID: 30027701
[TBL] [Abstract][Full Text] [Related]
11. Utilization of Truenat chips in defining XDR, pre-XDR and MDR in tuberculous meningitis.
Sharma K; Sharma M; Shree R; Singla N; Joshi H; Modi T; Goyal M; Sharma A; Sharma N; Modi M
Tuberculosis (Edinb); 2024 Jul; 147():102513. PubMed ID: 38547569
[TBL] [Abstract][Full Text] [Related]
12. [Study on the resistance of rifampicin-resistant Mycobacterium tuberculosis to anti-tuberculosis drugs in group A].
Dai XW; Li CY; Wang NH; Chen SS; Tian LL; Zhao YF; Tao LY; Yang XY; Ding BC; He XX
Zhonghua Jie He He Hu Xi Za Zhi; 2023 Nov; 46(11):1110-1117. PubMed ID: 37914422
[No Abstract] [Full Text] [Related]
13. Extensively drug-resistant tuberculosis in Myanmar: burden and mutations causing second-line drug resistance.
Ei PW; Aung WW; Nyunt WW; Swe TL; Htwe MM; Win SM; Aung ST; Chang CL; Lee HY; Lee JS
Int J Tuberc Lung Dis; 2018 Jan; 22(1):47-53. PubMed ID: 29297425
[TBL] [Abstract][Full Text] [Related]
14. Systematic evaluation of line probe assays for the diagnosis of tuberculosis and drug-resistant tuberculosis.
Lin M; Chen YW; Li YR; Long LJ; Qi LY; Cui TT; Wu SY; Lin JY; Wu T; Yang YC; Yuan WH; Wu GY; Lan QW; Liu JQ; Li YP; Yu ZY; Guo XG
Clin Chim Acta; 2022 Aug; 533():183-218. PubMed ID: 35792161
[TBL] [Abstract][Full Text] [Related]
15. Evolving rifampicin and isoniazid mono-resistance in a high multidrug-resistant and extensively drug-resistant tuberculosis region: a retrospective data analysis.
Mvelase NR; Balakrishna Y; Lutchminarain K; Mlisana K
BMJ Open; 2019 Nov; 9(11):e031663. PubMed ID: 31699736
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for extensive drug resistance in multidrug-resistant tuberculosis cases: a case-case study.
Guglielmetti L; Veziris N; Aubry A; Brossier F; Bernard C; Sougakoff W; Jarlier V; Robert J
Int J Tuberc Lung Dis; 2018 Jan; 22(1):54-59. PubMed ID: 29297426
[TBL] [Abstract][Full Text] [Related]
17. First insights into the phylogenetic diversity of Mycobacterium tuberculosis in Kuwait and evaluation of REBA MTB-MDR assay for rapid detection of MDR-TB.
Al-Mutairi NM; Ahmad S; Mokaddas E; Al-Hajoj S
PLoS One; 2022; 17(10):e0276487. PubMed ID: 36264939
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
Park SK; Kim JH; Kang H; Cho JS; Smego RA
Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
[TBL] [Abstract][Full Text] [Related]
19. Evidence-based Definition for Extensively Drug-Resistant Tuberculosis.
Roelens M; Battista Migliori G; Rozanova L; Estill J; Campbell JR; Cegielski JP; Tiberi S; Palmero D; Fox GJ; Guglielmetti L; Sotgiu G; Brust JCM; Bang D; Lienhardt C; Lange C; Menzies D; Keiser O; Raviglione M
Am J Respir Crit Care Med; 2021 Sep; 204(6):713-722. PubMed ID: 34107231
[No Abstract] [Full Text] [Related]
20. Incidence and risk factors for extensively drug-resistant tuberculosis in Delhi region.
Porwal C; Kaushik A; Makkar N; Banavaliker JN; Hanif M; Singla R; Bhatnagar AK; Behera D; Pande JN; Singh UB
PLoS One; 2013; 8(2):e55299. PubMed ID: 23390524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
